1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Asia Pacific Lung Cancer Therapy Market, by Country

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Lung Cancer Therapy Market - Key Industry Dynamics

4.1 Market Drivers:

4.1.1 Increase in Cases of Lung Cancer

4.1.2 Government Initiatives for Screening and Treatment of Lung Cancer

4.2 Market Restraints

4.2.1 High Cost of Lung Cancer Therapy

4.3 Market Opportunities

4.3.1 Rising Number of Lung Cancer Therapy in Clinical Trials

4.4 Future Trends

4.4.1 Growing Demand for Targeted Therapy

4.5 Impact Analysis:

5. Lung Cancer Therapy Market - Asia Pacific Market Analysis

5.1 Asia Pacific Lung Cancer Therapy Market Revenue (US$ Mn), 2020 - 2030

6. Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by Therapy Type

6.1 Overview

6.2 Asia Pacific Lung Cancer Therapy Market Revenue Share, by Therapy Type, 2022 & 2030 (%)

6.3 Non-Invasive Therapy

6.3.1 Overview

6.3.2 Non-Invasive Therapy: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Minimally Invasive

6.4.1 Overview

6.4.2 Minimally Invasive: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

6.4.3 Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

7. Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by Indication

7.1 Overview

7.2 Asia Pacific Lung Cancer Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)

7.3 Non-Small Cell Lung Cancer

7.3.1 Overview

7.3.2 Non-Small Cell Lung Cancer: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Small Cell Lung Cancer

7.4.1 Overview

7.4.2 Small Cell Lung Cancer: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by End User

8.1 Overview

8.2 Asia Pacific Lung Cancer Therapy Market Revenue Share, by End User, 2022 & 2030 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Oncology Clinics

8.4.1 Overview

8.4.2 Oncology Clinics: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Research Centers

8.5.1 Overview

8.5.2 Research Centers: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Lung Cancer Therapy Market - Country Analysis

9.1.1 Asia Pacific Asia Pacific Lung Cancer Therapy Market, by Country

9.1.1.1 China

9.1.1.1.1 Overview

9.1.1.1.2 China: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.1.3 China: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.1.3.1 China: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.1.4 China: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.1.5 China: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.2 Japan

9.1.1.2.1 Overview

9.1.1.2.2 Japan: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.2.3 Japan: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.2.3.1 Japan: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.2.4 Japan: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.2.5 Japan: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.3 India

9.1.1.3.1 Overview

9.1.1.3.2 India Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.3.3 India: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.3.3.1 India: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.3.4 India: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.3.5 India: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.4 Australia

9.1.1.4.1 Overview

9.1.1.4.2 Australia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.4.3 Australia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.4.3.1 Australia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.4.4 Australia: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.4.5 Australia: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.5 South Korea

9.1.1.5.1 Overview

9.1.1.5.2 South Korea: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.5.3 South Korea: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.5.3.1 South Korea: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.5.4 South Korea: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.5.5 South Korea: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.6 Southeast Asia

9.1.1.6.1 Overview

9.1.1.6.2 Southeast Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.6.3 Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.6.3.1 Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.6.4 Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.6.5 Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.6.6 Singapore

9.1.1.6.6.1 Singapore: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.6.6.2 Singapore: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.6.6.2.1 Singapore: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.6.6.3 Singapore: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.6.6.4 Singapore: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.6.7 Malaysia

9.1.1.6.7.1 Malaysia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.6.7.2 Malaysia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.6.7.2.1 Malaysia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.6.7.3 Malaysia: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.6.7.4 Malaysia: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.6.8 Indonesia

9.1.1.6.8.1 Indonesia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.6.8.2 Indonesia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.6.8.2.1 Indonesia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.6.8.3 Indonesia: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.6.8.4 Indonesia: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.6.9 Vietnam

9.1.1.6.9.1 Vietnam: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.6.9.2 Vietnam: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.6.9.2.1 Vietnam: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.6.9.3 Vietnam: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.6.9.4 Vietnam: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.6.10 Cambodia

9.1.1.6.10.1 Cambodia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.6.10.2 Cambodia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.6.10.2.1 Cambodia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.6.10.3 Cambodia: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.6.10.4 Cambodia: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.6.11 Philippines

9.1.1.6.11.1 Philippines: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.6.11.2 Philippines: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.6.11.2.1 Philippines: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.6.11.3 Philippines: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.6.11.4 Philippines: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.6.12 Rest of Southeast Asia

9.1.1.6.12.1 Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.6.12.2 Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.6.12.2.1 Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.6.12.3 Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.6.12.4 Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.7 Rest of Asia Pacific

9.1.1.7.1 Overview

9.1.1.7.2 Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.7.3 Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.7.3.1 Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.7.4 Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.7.5 Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

10. Lung Cancer Therapy Market - Industry Landscape

10.1 Overview

10.2 Growth Strategies in Asia Pacific Lung Cancer Therapy Market

10.3 Inorganic Growth Strategies

10.3.1 Overview

10.4 Organic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 Medtronic Plc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 RF Medical Co Ltd

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Johnson & Johnson

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Merck KGaA

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Sun Pharmaceutical Industries Ltd

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Bioventus Inc

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Olympus Corp

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Meiji Seika Pharma Co Ltd

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Advanz Pharma Corp

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Asia Pacific Lung Cancer Therapy Market Segmentation

Table 2. Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 3. China: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 4. China: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 5. China: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 6. China Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 7. Japan Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 8. Japan: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 9. Japan Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 10. Japan: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 11. India: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 12. India: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 13. India: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 14. India: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 15. Australia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 16. Australia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 17. Australia: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 18. Australia: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 19. South Korea: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 20. South Korea: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 21. South Korea: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 22. South Korea: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 23. Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 24. Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 25. Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 26. Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 27. Singapore: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 28. Singapore: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 29. Singapore: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 30. Singapore: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 31. Malaysia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 32. Malaysia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 33. Malaysia: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 34. Malaysia: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 35. Indonesia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 36. Indonesia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 37. Indonesia: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 38. Indonesia: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 39. Vietnam: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 40. Vietnam: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 41. Vietnam: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 42. Vietnam: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 43. Cambodia Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 44. Cambodia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 45. Cambodia: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 46. Cambodia: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 47. Philippines: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 48. Philippines: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 49. Philippines: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 50. Philippines: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 51. Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 52. Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 53. Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 54. Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 55. Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 56. Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 57. Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 58. Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 59. Recent Inorganic Growth Strategies in the Asia Pacific Lung Cancer Therapy Market

Table 60. Recent Organic Growth Strategies in Asia Pacific Lung Cancer Therapy Market

Table 61. Glossary of Terms, Asia Pacific Lung Cancer Therapy Market

List of Figures

Figure 1. Asia Pacific Lung Cancer Therapy Market Segmentation, By Country

Figure 2. Asia Pacific Lung Cancer Therapy Market - Key Industry Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Asia Pacific Lung Cancer Therapy Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Asia Pacific Lung Cancer Therapy Market Revenue Share, by Therapy Type, 2022 & 2030 (%)

Figure 6. Non-Invasive Therapy: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Minimally Invasive: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Asia Pacific Lung Cancer Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)

Figure 9. Non-Small Cell Lung Cancer: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Small Cell Lung Cancer: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Asia Pacific Lung Cancer Therapy Market Revenue Share, End User, 2022 & 2030 (%)

Figure 12. Hospitals: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Oncology Clinics: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Research Centers: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Others: Asia Pacific Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Asia Pacific Asia Pacific Lung Cancer Therapy Market, by Key Country - Revenue, 2022 (US$ Million)

Figure 17. Asia Pacific Asia Pacific Lung Cancer Therapy Market, By Key Countries, 2022 and 2030 (%)

Figure 18. China: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 19. Japan: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 20. India: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 21. Australia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 22. South Korea: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 23. Southeast: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 24. Singapore: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 25. Malaysia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. Indonesia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. Vietnam: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 28. Cambodia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 29. Philippines: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 30. Rest of Southeast Asia: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 31. Rest of Asia Pacific: Asia Pacific Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 32. Growth Strategies in Asia Pacific Lung Cancer Therapy Market